These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21520864)

  • 21. Collision-kerma conversion between dose-to-tissue and dose-to-water by photon energy-fluence corrections in low-energy brachytherapy.
    Giménez-Alventosa V; Antunes PC; Vijande J; Ballester F; Pérez-Calatayud J; Andreo P
    Phys Med Biol; 2017 Jan; 62(1):146-164. PubMed ID: 27991455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can intermediate-energy sources lead to elevated bone doses for prostate and head & neck high-dose-rate brachytherapy?
    Famulari G; Alfieri J; Duclos M; Vuong T; Enger SA
    Brachytherapy; 2020; 19(2):255-263. PubMed ID: 31964601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose reduction in LDR brachytherapy by implanted prostate gold fiducial markers.
    Landry G; Reniers B; Lutgens L; Murrer L; Afsharpour H; de Haas-Kock D; Visser P; van Gils F; Verhaegen F
    Med Phys; 2012 Mar; 39(3):1410-7. PubMed ID: 22380373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the relative biological effectiveness of low energy electronic brachytherapy sources in breast tissue: a Monte Carlo study.
    White SA; Reniers B; de Jong EE; Rusch T; Verhaegen F
    Phys Med Biol; 2016 Jan; 61(1):383-99. PubMed ID: 26674746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simulation study on potential accuracy gains from dual energy CT tissue segmentation for low-energy brachytherapy Monte Carlo dose calculations.
    Landry G; Granton PV; Reniers B; Ollers MC; Beaulieu L; Wildberger JE; Verhaegen F
    Phys Med Biol; 2011 Oct; 56(19):6257-78. PubMed ID: 21896967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-specific Monte Carlo dose calculations for (103)Pd breast brachytherapy.
    Miksys N; Cygler JE; Caudrelier JM; Thomson RM
    Phys Med Biol; 2016 Apr; 61(7):2705-29. PubMed ID: 26976478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical comparison of head and neck and prostate IMRT plans using absorbed dose to medium and absorbed dose to water.
    Dogan N; Siebers JV; Keall PJ
    Phys Med Biol; 2006 Oct; 51(19):4967-80. PubMed ID: 16985281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
    Chen Z; Nath R
    Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
    Mille MM; Xu XG; Rivard MJ
    Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 103Pd strings: Monte Carlo assessment of a new approach to brachytherapy source design.
    Rivard MJ; Reed JL; DeWerd LA
    Med Phys; 2014 Jan; 41(1):011716. PubMed ID: 24387508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
    Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
    Brachytherapy; 2014; 13(6):603-10. PubMed ID: 24913435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations.
    Jones BL; Krishnan S; Cho SH
    Med Phys; 2010 Jul; 37(7):3809-16. PubMed ID: 20831089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT-based dosimetry calculations for 125I prostate implants.
    DeMarco JJ; Smathers JB; Burnison CM; Ncube QK; Solberg TD
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1347-53. PubMed ID: 10613332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric impact of dual-energy CT tissue segmentation for low-energy prostate brachytherapy: a Monte Carlo study.
    Remy C; Lalonde A; Béliveau-Nadeau D; Carrier JF; Bouchard H
    Phys Med Biol; 2018 Jan; 63(2):025013. PubMed ID: 29260727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulation evaluation of NIST air-kerma rate calibration standard for electronic brachytherapy.
    Hiatt JR; Rivard MJ; Hughes HG
    Med Phys; 2016 Mar; 43(3):1119-29. PubMed ID: 26936699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of interseed attenuation and tissue composition for permanent prostate implants.
    Carrier JF; Beaulieu L; Therriault-Proulx F; Roy R
    Med Phys; 2006 Mar; 33(3):595-604. PubMed ID: 16878563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.